C2ORF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.75400000079762E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.40510000196304E-08 |
Normal-vs-Stage2 |
3.980400E-02 |
Normal-vs-Stage3 |
3.32960000015703E-07 |
Normal-vs-Stage4 |
1.05959996332672E-09 |
Stage1-vs-Stage2 |
3.684800E-01 |
Stage1-vs-Stage3 |
2.605800E-01 |
Stage1-vs-Stage4 |
6.730400E-02 |
Stage2-vs-Stage3 |
1.614640E-01 |
Stage2-vs-Stage4 |
7.855600E-02 |
Stage3-vs-Stage4 |
5.783600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.62080000216159E-08 |
Normal-vs-AfricanAmerican |
3.48200000055421E-07 |
Normal-vs-Asian |
1.422630E-04 |
Caucasian-vs-AfricanAmerican |
6.264800E-01 |
Caucasian-vs-Asian |
3.902600E-01 |
AfricanAmerican-vs-Asian |
7.602000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.17510001518673E-09 |
Normal-vs-Female |
1.61985000000087E-05 |
Male-vs-Female |
1.058590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.83254999999161E-05 |
Normal-vs-Age(41-60Yrs) |
9.55710000027921E-07 |
Normal-vs-Age(61-80Yrs) |
5.8768999999792E-08 |
Normal-vs-Age(81-100Yrs) |
1.916910E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.073600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.434000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.846200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.074600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.935200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.503000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.111500E-02 |
Normal-vs-Grade 2 |
1.553250E-04 |
Normal-vs-Grade 3 |
1.21830001642564E-09 |
Normal-vs-Grade 4 |
3.47455397786689E-12 |
Grade 1-vs-Grade 2 |
8.052200E-01 |
Grade 1-vs-Grade 3 |
1.421150E-01 |
Grade 1-vs-Grade 4 |
9.921100E-03 |
Grade 2-vs-Grade 3 |
8.076200E-03 |
Grade 2-vs-Grade 4 |
2.07929999999079E-05 |
Grade 3-vs-Grade 4 |
1.107810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.595700E-03 |
Normal-vs-ccB subtype |
6.59490018151132E-10 |
ccA subtype-vs-ccB subtype |
2.31229999999583E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.45309999997212E-07 |
Normal-vs-N1 |
2.13339999999285E-05 |
N0-vs-N1 |
1.000590E-01 |
|
|